Nanomicellar paclitaxel increases cytotoxicity of multidrug resistant breast cancer cells
about
Effect of Fe(3)O(4)-magnetic nanoparticles on acute exercise enhanced KCNQ(1) expression in mouse cardiac muscleStrategy for increasing drug solubility and efficacy through covalent attachment to polyvalent DNA-nanoparticle conjugates.2'-(2-bromohexadecanoyl)-paclitaxel conjugate nanoparticles for the treatment of non-small cell lung cancer in an orthotopic xenograft mouse model.A new lipid-based nano formulation of vinorelbineExposure to nanoparticles and hormesis.Impact of nanotechnology in cancer: emphasis on nanochemopreventionA critical review of lipid-based nanoparticles for taxane delivery.VIP-targeted Cytotoxic Nanomedicine for Breast CancerKey structure of brij for overcoming multidrug resistance in cancerVasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide, and their receptors and cancerNanoparticle delivery of natural products in the prevention and treatment of cancers: current status and future prospects.Paclitaxel Nano-Delivery Systems: A Comprehensive Review.Nanoparticles engineered from lecithin-in-water emulsions as a potential delivery system for docetaxelCurcumin in VIP-targeted sterically stabilized phospholipid nanomicelles: a novel therapeutic approach for breast cancer and breast cancer stem cells.Advances in novel drug delivery strategies for breast cancer therapy.Peptide delivery using phospholipid micelles.Progress in nanotechnology based approaches to enhance the potential of chemopreventive agents.Potential nanotechnologies and molecular targets in the quest for efficient chemotherapy in ovarian cancer.Impact of nanotechnology on the delivery of natural products for cancer prevention and therapy.Nanotechnology and traditional medicine: challenges and opportunities.Human pancreatic polypeptide in a phospholipid-based micellar formulation.Paclitaxel-loaded poly(n-butylcyanoacrylate) nanoparticle delivery system to overcome multidrug resistance in ovarian cancer.Neuropeptide G Protein-Coupled Receptors as Oncotargets.Strategies to improve micelle stability for drug delivery
P2860
Q33738469-4BD241E3-06FF-4BA5-98A9-FBFB3A5F94DAQ33980411-25A0DD40-5321-4D97-A6A8-63E3F0B8B16EQ34011693-DD3E9541-816D-4865-9F66-71187C0FB7EBQ34265212-6D3452A4-4D21-496D-A8C3-023E1626A023Q34341943-72C6D733-BE45-427C-9123-C92B842F36AFQ35750624-2E2A3678-565C-4820-B5F3-29C320A32ACBQ36360764-B4D91B5D-814D-462F-BA44-80F3255427D4Q36538910-AD2E61E3-70D7-49B7-9ADA-612AD3138A8DQ36615913-188FC239-EF63-484E-8AA6-F1D3CC256F8CQ36834005-67393669-82DF-4945-8975-26BD75C22968Q37148172-59C48325-A4D7-45D5-87C0-4C8B66715431Q37250009-3CF8CBC8-E5F2-4DC5-869F-7B09034756FAQ37330824-3CD18887-54AA-43C4-A0A4-7A3015B4E0DBQ37401138-750D6433-595E-436B-A49E-7939F50D99E0Q37777142-9D35002E-F290-4217-83E5-B93D20614A6EQ38030889-E22E23CF-2D11-4656-A41E-0ADA1C7C5774Q38161333-27318588-8A47-40EB-9B40-31BD29DE549DQ38258602-FFA5311F-9DF1-4D83-A474-E08095388746Q38758194-6ED781EB-D683-4FA0-B54A-890CD4DD8DBBQ38792790-B7482B1C-112D-4BB9-BFD5-F3B4BE14B67DQ39383638-2BF01884-8FD0-461B-933E-03002497B9E3Q39616068-6962C0B9-9C40-4089-A43A-F8E1B50BF455Q55709770-C6716950-7A14-44A7-90AD-B0872B83BD6FQ58125662-1768E206-11A6-4C5D-8D76-3266CC5DAB18
P2860
Nanomicellar paclitaxel increases cytotoxicity of multidrug resistant breast cancer cells
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Nanomicellar paclitaxel increases cytotoxicity of multidrug resistant breast cancer cells
@en
Nanomicellar paclitaxel increa ...... resistant breast cancer cells.
@nl
type
label
Nanomicellar paclitaxel increases cytotoxicity of multidrug resistant breast cancer cells
@en
Nanomicellar paclitaxel increa ...... resistant breast cancer cells.
@nl
prefLabel
Nanomicellar paclitaxel increases cytotoxicity of multidrug resistant breast cancer cells
@en
Nanomicellar paclitaxel increa ...... resistant breast cancer cells.
@nl
P2093
P2860
P1433
P1476
Nanomicellar paclitaxel increases cytotoxicity of multidrug resistant breast cancer cells
@en
P2093
Eunjung Jeon
Hayat Onyüksel
Israel Rubinstein
P2860
P304
P356
10.1016/J.CANLET.2008.09.041
P407
P577
2008-11-20T00:00:00Z